Published in Medicine and Law Weekly, October 29th, 2004
To date, a total of 24 patients who suffered from severe mitral valve regurgitation (MR) have received the clip as part of a clinical study under an FDA-approved investigational device exemption (IDE). The clip is a product of medical device company Evalve Inc., located in Redwood City, California. Based on these promising results, a larger, phase II safety and efficacy trial may be initiated later this year.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.